Sageworth Trust CO Zoetis Inc. Transaction History

Sageworth Trust CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	BUY	$155.97 - $200.09 $72,526 - $93,041	465 New	465 $80,000
Q3 2020 Nov 04, 2020	SELL	$137.1 - $165.37 $274 - $330	-2 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$111.92 - $142.53 $223 - $285	2 New	2 $0
Q2 2019 Jul 19, 2019	SELL	$97.98 - $114.28 $2,841 - $3,314	-29 Closed	0 $0
Q1 2019 Apr 08, 2019	BUY	$81.56 - $100.67 $1,549 - $1,912	19 Added 190.0%	29 $3,000
Q4 2018 Jan 18, 2019	SELL	$79.28 - $95.27 $19,106 - $22,960	-241 Reduced 96.02%	10 $1,000
Q2 2018 Jul 19, 2018	BUY	$79.9 - $89.2 $9,667 - $10,793	121 Added 93.08%	251 $21,000
Q1 2018 May 03, 2018	BUY	$71.51 - $84.69 $9,010 - $10,670	126 Added 3150.0%	130 $11,000
Q4 2017 Jan 31, 2018	BUY	$63.24 - $72.8 $252 - $291	4	4 $0

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Sageworth Trust CO, based on Form 13F filings with the SEC.

Stay updated on Sageworth Trust CO with notifications on news.